Meeting to be held in New York on October 23-27 hosted by Piper Sandler.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CMPX:
- Promising Outlook for Compass Therapeutics: Buy Rating Backed by COMPANION-002 Trial Success and Market Potential
- Buy Rating for Compass Therapeutics Driven by Promising Clinical Trial Data and Strategic Enrollment
- Compass Therapeutics initiated with an Outperform at LifeSci Capital
- Positive Outlook for Compass Therapeutics: Buy Rating Backed by Promising Pipeline and Market Potential
- Compass Therapeutics management to meet with Piper Sandler